Author

Kun Zhao

Vanderbilt UniversityORCID 0009-0007-7497-1773Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Kun Zhao5 papers · Vanderbilt University

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:gene regulatory network inference· 1 Research Focus:GWAS / association mapping· 1 Assay:GWAS summary statistics· 1

Frequent Co-Authors

Alexander G. BickiD· 2 shared Jonathan Brett HeimlichiD· 2 shared Robert W. CortyiD· 2 shared Yash PershadiD· 2 shared Alex P. ReineriD· 1 shared Alexander James SilveriD· 1 shared Alyssa ParkeriD· 1 shared Ashwin KishtagariiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Alexander G. BickORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genetic & Genomic MedicinemedRxivPreprintApr 5, 2026

Mutation-specific impairment of TET2 and DNMT3A enzymatic activity predicts clonal hematopoiesis disease risk

Yash Pershad, Kun Zhao, Joseph C. Van Amburg…·Alexander G. Bick

The paper identifies mutation-specific impairments in TET2 and DNMT3A enzymatic activity as predictors of clonal hematopoiesis disease risk using methylation-based activity scores.

1 citation

humanDNA methylation

𝕏 PostBluesky

Genetic & Genomic MedicinemedRxivPreprintOct 22, 2025

Clonal Hematopoiesis and Risk of Stroke: Evidence from Over 800,000 Individuals Across Three Cohorts

Kun Zhao, Yash Pershad, Liying Xue…·Alexander G. Bick

This study finds that clonal hematopoiesis (CHIP) increases stroke risk across multiple cohorts, with specific gene mutations and inflammatory markers like IL-1RAP modifying this risk.

DOI 10.1101/2025.10.22.25338594

humanGWAS summary statistics

𝕏 PostBluesky